The Latest Breaking News from Central Garden Pet

Has This Top 100 Stock to Buy Gone to the Dogs?

Highflying Dogness Corp. jumped more than 13% Monday, reentering Barchart’s Top 100 Stocks to Buy in the 61st spot. Up nearly 460% in 2024, the marketer of pet-related products has a nosebleed valuation at current price. FOMO is definitely in play here.

Barchart · Oct 15, 2024

Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022

Upgrades

Benzinga · Aug 25, 2022

Earnings Scheduled For May 4, 2022

  Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.

Benzinga · May 4, 2022